Get started
Author

Sara Caratelli

Observed names: Caratelli, Sara, S Caratelli, S. Caratelli
ORCID: 0000-0002-6090-0444
Observed ORCID: 0000-0002-6090-0444
OpenAlex ID: A5033802441
NK cells and T cells cooperate during the clinical course of colorectal cancer
2014 · Giuseppe Sconocchia, Serenella Eppenberger, et al. · OncoImmunology · 166
PDF
HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker
2014 · Giuseppe Sconocchia, Serenella Eppenberger-Castori, et al. · Neoplasia · 134
PDF
Peroxiredoxin 6, a Novel Player in the Pathogenesis of Diabetes
2014 · Francesca Pacifici, Roberto Arriga, et al. · Diabetes · 111
FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance
2017 · Sara Caratelli, Tommaso Sconocchia, et al. · Frontiers in Immunology · 71
PDF
T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G–opsonized target cells
2015 · Maria Michela D'Aloia, Sara Caratelli, et al. · Cytotherapy · 54
In vitro elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab
2019 · Sara Caratelli, Roberto Arriga, et al. · International Journal of Cancer · 43
PDF
Serum glucocorticoid inducible kinase (SGK)-1 protects endothelial cells against oxidative stress and apoptosis induced by hyperglycaemia
2014 · Francesca Ferrelli, Donatella Pastore, et al. · Acta Diabetologica · 31
Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer
2025 · Hany E. Marei, Khaled Bedair, et al. · Cancer Cell International · 27
PDF
CD16‐158‐valine chimeric receptor T cells overcome the resistance of KRAS‐mutated colorectal carcinoma cells to cetuximab
2019 · Roberto Arriga, Sara Caratelli, et al. · International Journal of Cancer · 26
Recent perspective on CAR and Fcγ-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes
2019 · Hany E. Marei, Asma Althani, et al. · Biochemical Pharmacology · 25
Contribution of A-to-I RNA editing, M6A RNA Methylation, and Alternative Splicing to physiological brain aging and neurodegenerative diseases
2023 · Valentina Tassinari, Piergiorgio La Rosa, et al. · Mechanisms of Ageing and Development · 20
HLA‐DRB1 *13:01 allele in the genetic susceptibility to colorectal carcinoma
2014 · Anna Aureli, Angelica Canossi, et al. · International Journal of Cancer · 20
Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application
2022 · Hany E. Marei, Asmaa Althani, et al. · Discover Oncology · 15
PDF
Enhancement of anti-leukemia activity of NK cellsin vitroandin vivoby inhibition of leukemia cell-induced NK cell damage
2015 · Roberto Arriga, Sara Caratelli, et al. · Oncotarget · 13
Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology
2015 · Barbara Capuani, David Della-Morte, et al. · American Journal of Physiology-Endocrinology and Metabolism · 10
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment
2022 · Giuseppe Sconocchia, Giulia Lanzilli, et al. · Life Science Alliance · 5
PDF
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity
2025 · Sara Caratelli, Francesca De Paolis, et al. · Experimental Hematology and Oncology · 4
PDF
Egfr Glioblastoma Stem Cells Targeting by Cd16158v Chimeric Receptor T Cells and Cetuximab
2021 · C. Cenciarelli, S. Caratelli, et al. · Annals of Research in Oncology · 2
PDF
Immunotherapy of diffuse large B-cell lymphoma: from monoclonal antibodies to cellular therapies. A narrative review
2026 · Anna Aureli, Giulia Lanzilli, et al. · Frontiers in Immunology · 1
PDF
Recent advances in molecular mechanisms to improve the efficacy of CAR-T cell therapy for viral diseases, cancer, and autoimmune diseases
2026 · Hany E. Marei, Giacomo Pozzoli, et al. · Stem Cell Research & Therapy
FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy
2026 · Hany E. Marei, Giacomo Pozzoli, et al. · Cancer Cell International
Abstract 4050: Association of long term NK cell culture and TIMP3 over-expression with NK cell reduced susceptibility to leukemia and epithelial cancer cell induced damage
2015 · Giuseppe Sconocchia, Roberto Arriga, et al. · Cancer Research
P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy
2014 · G Sconocchia, R Arriga, et al. · Journal for ImmunoTherapy of Cancer
PDF
Works count: 25
Citation count: 778
H-index: 13
I10-index: 15
Year
Topic
Type